Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

PureTech Health Presented Results From The Phase 1 Portion Of The Phase 1/2 Dose Escalation And Expansion Clinical Trial Of LYT-200 Targeting Galectin-9 In Solid Tumors

Author: Benzinga Newsdesk | December 07, 2023 07:18am

Posted In: PRTC